SEC Form 4 · accession 0001104659-17-022871
Hepion Pharmaceuticals, Inc. · HEPA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tamar D Howson
Director
Period of report
Apr 10, 2017
Accepted (ET)
Apr 11, 2017 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583771
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $1.60 | Apr 10, 2017 | A | 35,000 | A | — | Apr 10, 2027 | Common Stock | 35,000 | 80,000 | D |
Explanation of responses
- F1Options vest in three installments as follows: 11,667 of the options vest on each of April 10, 2018 and 2019 and 11,666 vest on April 10, 2020.